These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10981052)

  • 1. Obesity, hypertension, and sympathetic nervous system activity.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 1999; 1(2):119-26. PubMed ID: 10981052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
    Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
    Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sympathetic nervous system in essential hypertension.
    Tuck ML
    Am Heart J; 1986 Oct; 112(4):877-86. PubMed ID: 3532745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural mechanisms in human obesity-related hypertension.
    Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
    J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in mechanisms between weight loss-sensitive and -resistant blood pressure reduction in obese subjects.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Hypertens Res; 2001 Jul; 24(4):371-6. PubMed ID: 11510749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise.
    Masuo K; Rakugi H; Ogihara T; Lambert GW
    Hypertens Res; 2012 Jan; 35(1):41-7. PubMed ID: 21814218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
    Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
    J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the sympathetic nervous system.
    Grassi G; Cattaneo BM; Seravalle G; Colombo M; Cavagnini F; Mancia G
    Blood Press Suppl; 1996; 1():43-6. PubMed ID: 9162437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
    Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
    Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activity and body mass index contribute to blood pressure levels.
    Masuo K; Mikami H; Itoh M; Ogihara T; Tuck ML
    Hypertens Res; 2000 Jul; 23(4):303-10. PubMed ID: 10912765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain-induced blood pressure elevation.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Hypertension; 2000 May; 35(5):1135-40. PubMed ID: 10818077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic overactivity in hypertension and cardiovascular disease.
    Manolis AJ; Poulimenos LE; Kallistratos MS; Gavras I; Gavras H
    Curr Vasc Pharmacol; 2014 Jan; 12(1):4-15. PubMed ID: 23905597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
    Schlaich MP; Lambert E; Kaye DM; Krozowski Z; Campbell DJ; Lambert G; Hastings J; Aggarwal A; Esler MD
    Hypertension; 2004 Feb; 43(2):169-75. PubMed ID: 14610101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial obesity, sympathetic activation and blood pressure level.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Blood Press; 2001; 10(4):199-204. PubMed ID: 11800057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.